Sherwin-Williams enters the week carrying a 13% one-month decline and a stock that options traders are beginning to treat as a buying opportunity rather than a short — yet the analyst community has spent six weeks steadily marking down where fair value sits.
The most striking feature of the current setup is the divergence between price action and options sentiment. The stock fell another 4% on the week to $299.05, and is down 13% over the past month. But the put/call ratio has dropped to 0.61 — below its 20-day average of 0.67 and running near the lower end of its 52-week range (0.51–1.25). That is not the profile of a market bracing for further downside. Options traders are leaning call-heavy relative to recent norms, with the z-score at -0.83. The RSI has pressed into the mid-30s, a level that in most definitions signals an oversold condition.
Short interest tells a straightforward story: there is very little of it. SI sits at 2.4% of the free float — up 11% over the past month in share terms, but the absolute level remains low. Borrow is essentially free at 0.16%, having halved just this week from an already negligible 0.41%. Availability is about as loose as it gets. The lending market is not the story here. The ORTEX short score of 33.6 sits in the 40th percentile of the broader universe, consistent with a stock that shorts are watching but not crowding.
The Street is the more interesting angle. The consensus is still nominally bullish — 11 buys against 10 holds — and the mean price target of $381 implies roughly 27% upside from current levels. But the direction of travel has been relentlessly lower. Post-Q1 earnings on April 28, JP Morgan trimmed its target from $385 to $365 while holding Overweight; Wells Fargo cut from $365 to $350 and maintained Equal-Weight. Evercore ISI was the outlier, nudging its Outperform target up from $390 to $400 on May 8. The broader picture across March and April: eight separate target reductions from firms including UBS, Citi, RBC, and Mizuho, most holding ratings but shaving numbers by $25–40. The compression in targets has been orderly, not panicked, but the trajectory is unambiguous. Valuation multiples reflect the slide — the P/E has contracted by nearly four turns over the past month to 24.3x, and EV/EBITDA has eased to 17.6x. The 12-month forward EPS growth expectation still ranks in the 91st percentile of the universe, which is the bull case's strongest remaining pillar.
Q1 results delivered the reset in full view. The stock fell 5.4% on April 28 and extended losses to 7% over the following five days. Management guided to flat-to-low-single-digit sales growth for 2025, pulling back from earlier positive low-single-digit expectations. The culprit is familiar: higher rates and affordability pressures squeezing housing activity. The 60 basis point gross margin expansion to 49.4% and the $80 million restructuring programme are real positives, and management flagged expected margin improvement in the second half. But the demand revision was enough to push the stock to levels not seen since before its post-pandemic recovery phase. Closest peers RPM and PPG fell 4.3% and 4.4% respectively on the week, so this is an industry-wide repricing rather than a Sherwin-specific dislocation — though AVNT led losses at -7.4% and NGVT dropped 9.1%, suggesting more cyclically exposed names are absorbing the most pressure.
The institutional picture is stable. Vanguard, BlackRock, and State Street together hold roughly 23% of shares, with all three modestly adding in recent filings. FMR (Fidelity) added 1.75 million shares through March, the largest active-manager move in the data. Insider activity on the data is dated to late February and largely reflects award-related sells at prices around $368 — above current levels — so it provides limited signal for today's setup.
The next scheduled earnings release is July 21. Between now and then, the question the data leaves open is whether the gap between a call-heavy options market and a Street still cutting targets narrows — and which side moves first to close it.
See the live data behind this article on ORTEX.
Open SHW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
